Identification of dimethyl 2,2’-((methylenebis(2-(2H-benzo[d][1,2,3]triazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)-6,1phenylene))bis(oxy))diacetate (TAJ4) as antagonist of NEK-Family: a future for potential drug discovery

Abstract The purpose of the current study was to analyze and validate the existing gap in knowledge, by conducting a differential expression analysis and validation of NEK6, NEK7, and NEK9 in breast, cervical, and glioblastoma cancer and targeting these proteins through development of novel site spe...

Full description

Saved in:
Bibliographic Details
Main Authors: Mubashir Aziz, Syeda Abida Ejaz, Pervaiz Ali Channar, Ali G. Alkhathami, Tahir Qadri, Zahid Hussain, Mumtaz Hussaain, Rabail Ujan
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-024-13269-4
Tags: Add Tag
No Tags, Be the first to tag this record!